[Radiotherapy in supratentorial low grade gliomas]. 2002

Francisco Mascarenhas, and José António Matos, and Maximino Ortiz, and Maria Francisca Pires, and Isabel Monteiro Grillo
Serviço de Radioterapia, Hospital de Santa Maria, Lisboa.

The management of the supratentorial low-grade gliomas has been a question of great debate in our days and the best therapeutic approach is still to determinate. The improvements in the modern surgical techniques have made feasible greater degrees of resection and have lead to longterm progression-free survival remaining surgery as the mainstay of treatment for low grade gliomas. A considerable proportion of patients will have less than complete removal or unresectable tumors and will need more efficacious treatment alternatives which must be identified. This article reviews the current state of knowledge concerning external radiation therapy with regard to the results of recent series, the side effects and potential benefits with newer radiotherapy techniques and provides recommendations with regard to management.

UI MeSH Term Description Entries
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001254 Astrocytoma Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082) Astrocytoma, Subependymal Giant Cell,Glioma, Astrocytic,Oligoastrocytoma, Mixed,Pleomorphic Xanthoastrocytomas,Anaplastic Astrocytoma,Astrocytoma, Grade I,Astrocytoma, Grade II,Astrocytoma, Grade III,Astrocytoma, Protoplasmic,Astroglioma,Cerebral Astrocytoma,Childhood Cerebral Astrocytoma,Fibrillary Astrocytoma,Gemistocytic Astrocytoma,Intracranial Astrocytoma,Juvenile Pilocytic Astrocytoma,Pilocytic Astrocytoma,Subependymal Giant Cell Astrocytoma,Anaplastic Astrocytomas,Astrocytic Glioma,Astrocytic Gliomas,Astrocytoma, Anaplastic,Astrocytoma, Cerebral,Astrocytoma, Childhood Cerebral,Astrocytoma, Fibrillary,Astrocytoma, Gemistocytic,Astrocytoma, Intracranial,Astrocytoma, Juvenile Pilocytic,Astrocytoma, Pilocytic,Astrocytomas,Astrocytomas, Grade III,Astrogliomas,Cerebral Astrocytoma, Childhood,Cerebral Astrocytomas,Childhood Cerebral Astrocytomas,Fibrillary Astrocytomas,Gemistocytic Astrocytomas,Gliomas, Astrocytic,Grade I Astrocytoma,Grade I Astrocytomas,Grade II Astrocytoma,Grade II Astrocytomas,Grade III Astrocytoma,Grade III Astrocytomas,Intracranial Astrocytomas,Juvenile Pilocytic Astrocytomas,Mixed Oligoastrocytoma,Mixed Oligoastrocytomas,Pilocytic Astrocytoma, Juvenile,Pilocytic Astrocytomas,Pleomorphic Xanthoastrocytoma,Protoplasmic Astrocytoma,Protoplasmic Astrocytomas,Xanthoastrocytoma, Pleomorphic
D015173 Supratentorial Neoplasms Primary and metastatic (secondary) tumors of the brain located above the tentorium cerebelli, a fold of dura mater separating the CEREBELLUM and BRAIN STEM from the cerebral hemispheres and DIENCEPHALON (i.e., THALAMUS and HYPOTHALAMUS and related structures). In adults, primary neoplasms tend to arise in the supratentorial compartment, whereas in children they occur more frequently in the infratentorial space. Clinical manifestations vary with the location of the lesion, but SEIZURES; APHASIA; HEMIANOPSIA; hemiparesis; and sensory deficits are relatively common features. Metastatic supratentorial neoplasms are frequently multiple at the time of presentation. Cancer, Supratentorial,Benign Supratentorial Neoplasms,Malignant Supratentorial Neoplasms,Neoplasms, Supratentorial,Primary Supratentorial Neoplasms,Supratentorial Neoplasms, Benign,Supratentorial Neoplasms, Malignant,Supratentorial Neoplasms, Primary,Supratentorial Tumors,Benign Supratentorial Neoplasm,Cancers, Supratentorial,Malignant Supratentorial Neoplasm,Neoplasm, Benign Supratentorial,Neoplasm, Malignant Supratentorial,Neoplasm, Primary Supratentorial,Neoplasm, Supratentorial,Neoplasms, Benign Supratentorial,Neoplasms, Malignant Supratentorial,Neoplasms, Primary Supratentorial,Primary Supratentorial Neoplasm,Supratentorial Cancer,Supratentorial Cancers,Supratentorial Neoplasm,Supratentorial Neoplasm, Benign,Supratentorial Neoplasm, Malignant,Supratentorial Neoplasm, Primary,Supratentorial Tumor,Tumor, Supratentorial,Tumors, Supratentorial
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D018570 Risk Assessment The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988) Assessment, Risk,Benefit-Risk Assessment,Risk Analysis,Risk-Benefit Assessment,Health Risk Assessment,Risks and Benefits,Analysis, Risk,Assessment, Benefit-Risk,Assessment, Health Risk,Assessment, Risk-Benefit,Benefit Risk Assessment,Benefit-Risk Assessments,Benefits and Risks,Health Risk Assessments,Risk Analyses,Risk Assessment, Health,Risk Assessments,Risk Benefit Assessment,Risk-Benefit Assessments

Related Publications

Francisco Mascarenhas, and José António Matos, and Maximino Ortiz, and Maria Francisca Pires, and Isabel Monteiro Grillo
March 1989, International journal of radiation oncology, biology, physics,
Francisco Mascarenhas, and José António Matos, and Maximino Ortiz, and Maria Francisca Pires, and Isabel Monteiro Grillo
January 1990, Neurosurgery clinics of North America,
Francisco Mascarenhas, and José António Matos, and Maximino Ortiz, and Maria Francisca Pires, and Isabel Monteiro Grillo
September 2005, Journal of neurosurgical sciences,
Francisco Mascarenhas, and José António Matos, and Maximino Ortiz, and Maria Francisca Pires, and Isabel Monteiro Grillo
July 1993, Oncology (Williston Park, N.Y.),
Francisco Mascarenhas, and José António Matos, and Maximino Ortiz, and Maria Francisca Pires, and Isabel Monteiro Grillo
December 2009, Neurology,
Francisco Mascarenhas, and José António Matos, and Maximino Ortiz, and Maria Francisca Pires, and Isabel Monteiro Grillo
January 1987, Neurologie et psychiatrie,
Francisco Mascarenhas, and José António Matos, and Maximino Ortiz, and Maria Francisca Pires, and Isabel Monteiro Grillo
December 2003, Seminars in oncology,
Francisco Mascarenhas, and José António Matos, and Maximino Ortiz, and Maria Francisca Pires, and Isabel Monteiro Grillo
December 2003, Seminars in oncology,
Francisco Mascarenhas, and José António Matos, and Maximino Ortiz, and Maria Francisca Pires, and Isabel Monteiro Grillo
August 2012, Neuro-oncology,
Francisco Mascarenhas, and José António Matos, and Maximino Ortiz, and Maria Francisca Pires, and Isabel Monteiro Grillo
January 1987, Zentralblatt fur Neurochirurgie,
Copied contents to your clipboard!